<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335560">
  <stage>Registered</stage>
  <submitdate>28/05/2010</submitdate>
  <approvaldate>4/06/2010</approvaldate>
  <actrnumber>ACTRN12610000458033</actrnumber>
  <trial_identification>
    <studytitle>Grape skin extract versus placebo in patients with metabolic syndrome and insulin resistance. A double blind, randomized, multicenter study.</studytitle>
    <scientifictitle>In adults with metabolic syndrome, is grape skin extract  combined with diet/exercise orientation effective in insulin resistance (measured using the homeostasis model assessment of insulin resistance [HOMA-IR] index), as compared to placebo plus diet/exercise orientation?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>metabolic syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other metabolic disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Two arms: 
1)grape skin extract 500 micrograms, three times a day, for 24 weeks; tablet 
2)placebo (microcellulose) 500 micrograms, three times a day, for 24 weeks; tablet

Both arms will have non-pharmacological treatment (specialised diet taken daily for 24 weeks/exercise orientation: regular light/moderate-intensity physical activity at least 30 minutes daily, 4-7 days/week) according to the First Brazilian Guideline on the Diagnosis and Treatment of The metabolic Syndrome- Brazilian Society of Cardiology</interventions>
    <comparator>placebo (microcellulose).</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>insulin resistance measured by the homeostasis model assessment of insulin resistance [HOMA-IR] index</outcome>
      <timepoint>all visits</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>blood pressure (using a calibrated sphygmomanometer)</outcome>
      <timepoint>all visits</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>lipids: high-density lipoprotein [HDL-c], low-density lipoprotein [LDL-c], total cholesterol, triglycerides (blood analysis)</outcome>
      <timepoint>all visits</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>diagnosis of metabolic syndrome
homeostasis model assessment of insulin resistance [HOMA-IR] &gt;2,7</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>hypertension (stages 2 and 3)
diabetes</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>30/08/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>128</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Ache Laboratories</primarysponsorname>
    <primarysponsoraddress>Rodovia Dutra km 222,2 Guarulhos, State of Sao Paulo Brazil CEP (ZIP) 07034-904</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Ache Laboratories</fundingname>
      <fundingaddress>Rodovia Dutra km 222,2 Guarulhos, State of Sao Paulo Brazil CEP (ZIP) 07034-904</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress>N/A</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In adults with metabolic syndrome the study will compare the efficacy of a grape skin extract combined with non-pharmacological treatment (diet/exercise orientation)  in insulin resistance (measured using the homeostasis model assessment of insulin resistance [HOMA-IR] index),  as compared to placebo plus non-pharmacological treatment (diet/exercise orientation). The hypothesis will consider the superiority of the grape skin extract therapy.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Fabio Ikedo</name>
      <address>Rodovia Dutra km 222,2
CEP 07034-904
Guarulhos
Sao Paulo
Brazil</address>
      <phone>55-11-26088181</phone>
      <fax />
      <email>fabio.ikedo@ache.com.br</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Fabio Ikedo</name>
      <address>Rodovia Dutra km 222,2
CEP 07034-904
Guarulhos
Sao Paulo
Brazil</address>
      <phone>55-11-26088181</phone>
      <fax />
      <email>fabio.ikedo@ache.com.br</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>